These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 11177224)

  • 1. Argatroban for treatment of heparin-induced thrombocytopenia.
    Med Lett Drugs Ther; 2001 Feb; 43(1097):11-2. PubMed ID: 11177224
    [No Abstract]   [Full Text] [Related]  

  • 2. Thrombotic end point for assessing argatroban therapy for heparin-induced thrombocytopenia: learning from secondary analyses of prospective studies.
    Warkentin TW
    Chest; 2006 Jun; 129(6):1396-8. PubMed ID: 16778250
    [No Abstract]   [Full Text] [Related]  

  • 3. Heparin-induced thrombocytopenia and the health economic analysis of argatroban.
    Coventry DA; Webster NR
    Br J Anaesth; 2014 Jun; 112(6):964-7. PubMed ID: 24569065
    [No Abstract]   [Full Text] [Related]  

  • 4. Argatroban for suspected heparin-induced thrombocytopenia: contemporary experience at a large teaching hospital.
    Kodityal S; Nguyen PH; Kodityal A; Sherer J; Hursting MJ; Rice L
    J Intensive Care Med; 2006; 21(2):86-92. PubMed ID: 16537750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticoagulation with Novastan (argatroban) in patients with heparin-induced thrombocytopenia and heparin-induced thrombocytopenia and thrombosis syndrome.
    Lewis BE; Walenga JM; Wallis DE
    Semin Thromb Hemost; 1997; 23(2):197-202. PubMed ID: 9200347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. INR matters: a case on managing argatroban for bridging oral anticoagulation in a patient with heparin induced thrombocytopenia type II after mechanical heart valve replacement.
    Raaz U; Maegdefessel L; Buerke M; Janusch M; Werdan K; Schlitt A
    Thromb Res; 2009 Jun; 124(2):242-3. PubMed ID: 19019411
    [No Abstract]   [Full Text] [Related]  

  • 7. Safety and efficacy of argatroban in patients with heparin-induced thrombocytopenia.
    Matthai WH
    Curr Hematol Rep; 2006 Mar; 5(1):95-9. PubMed ID: 16537053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complete salvage of impending free flap failure in heparin induced thrombocytopenia by emergent institution of therapy with argatroban.
    Schleich AR; Oswald TM; Lineaweaver WC
    J Plast Reconstr Aesthet Surg; 2008 Oct; 61(10):1263-4. PubMed ID: 18632316
    [No Abstract]   [Full Text] [Related]  

  • 9. The cost-effectiveness of argatroban treatment in heparin-induced thrombocytopenia: the effect of early versus delayed treatment.
    Arnold RJ; Kim R; Tang B
    Cardiol Rev; 2006; 14(1):7-13. PubMed ID: 16371760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Argatroban approved for heparin-induced thrombocytopenia.
    Miller JL
    Am J Health Syst Pharm; 2000 Sep; 57(18):1650. PubMed ID: 11006790
    [No Abstract]   [Full Text] [Related]  

  • 11. Successful Anticoagulation Using Argatroban During Transcatheter Aortic Valve Implantation in a Patient With Heparin-Induced Thrombocytopenia.
    Naganuma T; Mitomo S; Kin N; Nakamura S
    A A Case Rep; 2016 Oct; 7(7):158-60. PubMed ID: 27513970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparin-induced thrombocytopenia II-induced critical limb ischaemia treated with urokinase and argatroban.
    Beyer J; Halbritter K; Weise M; Leonhard J; Schellong S
    Thromb Haemost; 2007 Aug; 98(2):470-2. PubMed ID: 17721634
    [No Abstract]   [Full Text] [Related]  

  • 13. Thrombelastography in a patient with heparin-induced thrombocytopenia treated with argatroban.
    Zayac EA; Pivalizza EG; Levine RL
    Anesth Analg; 2008 Jan; 106(1):351-2. PubMed ID: 18165611
    [No Abstract]   [Full Text] [Related]  

  • 14. Pulmonary embolism and heparin-induced thrombocytopenia successfully treated with tissue plasminogen activator and argatroban.
    Hourmouzis Z; Bhalla MC; Frey JA; Jwayyed S
    Am J Emerg Med; 2015 May; 33(5):739.e5-6. PubMed ID: 25497698
    [No Abstract]   [Full Text] [Related]  

  • 15. Argatroban for percutaneous coronary interventions: hit or miss?
    Bittl JA
    Catheter Cardiovasc Interv; 2002 Oct; 57(2):185-6. PubMed ID: 12357517
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of heparin-induced thrombocytopenia by use of argatroban, a synthetic thrombin inhibitor.
    Matsuo T; Kario K; Chikahira Y; Nakao K; Yamada T
    Br J Haematol; 1992 Nov; 82(3):627-9. PubMed ID: 1486048
    [No Abstract]   [Full Text] [Related]  

  • 17. Heparin-induced thrombocytopenia in haemodialysis treated with argatroban.
    Quiñones-Ortiz L; Suárez-Laurés A; Pablos-de Pablo M; Robles V; Calzón-Blanco C; Quiñones-Pérez S; Ayausty-Ruiz A
    Nefrologia; 2014; 34(5):670-4. PubMed ID: 25036261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of argatroban during percutaneous coronary interventions in patients with heparin-induced thrombocytopenia.
    Matthai WH
    Semin Thromb Hemost; 1999; 25 Suppl 1():57-60. PubMed ID: 10357153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Managing argatroban in heparin-induced thrombocytopenia: A retrospective analysis of 729 treatment days in 32 patients with confirmed heparin-induced thrombocytopenia.
    Marchetti M; Barelli S; Gleich T; Gomez FJ; Goodyer M; Grandoni F; Alberio L
    Br J Haematol; 2022 Jun; 197(6):766-790. PubMed ID: 35358358
    [No Abstract]   [Full Text] [Related]  

  • 20. Heparin-induced thrombocytopenia with aortoiliac thrombosis treated with argatroban.
    Alarcón Pérez L; Rodríguez Huerta AM; Duque González P
    Med Clin (Barc); 2017 Mar; 148(6):286-287. PubMed ID: 28131516
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.